Cargando…
Evolving Role of Immunotherapy in Metastatic Castration Refractory Prostate Cancer
Immunotherapies have shown remarkable success in the treatment of multiple cancer types; however, despite encouraging preclinical activity, registration trials of immunotherapy in prostate cancer have largely been unsuccessful. Sipuleucel-T remains the only approved immunotherapy for the treatment o...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932934/ https://www.ncbi.nlm.nih.gov/pubmed/33369720 http://dx.doi.org/10.1007/s40265-020-01456-z |